Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2010) Neena S Abraham et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)

(2010) John L Wallace et al.   BRITISH JOURNAL OF PHARMACOLOGY

Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Ulcer: Looking to the Future

(2009) Stefano Fiorucci   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity

(2009) P. Vavassori et al.   JOURNAL OF IMMUNOLOGY

Bile acid-activated receptors in the treatment of dyslipidemia and related disorders

(2009) Stefano Fiorucci et al.   PROGRESS IN LIPID RESEARCH

Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation

(2009) Barbara Renga et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac

(2008) Loren Laine et al.   GASTROENTEROLOGY

Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development

(2008) R. R.M. Maran et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?

(2008) John L. Wallace   PHYSIOLOGICAL REVIEWS